ABCL included in ETFs
Dates are bounded by retained official portfolio snapshots; baseline presence is never presented as an original addition date.
Current ETFs holding ABCL
9 latest ETF portfolios currently report this security. This page shows rows 1–9 of 9.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| IDNA | iShares Genomics Immunology and Healthcare ETF | 1.063604% | 2026-04-30 | 2026-04-30 |
| BBC | Virtus Biotech Clinical Trials Etf | 0.847519% | 2021-07-30 | 2026-04-30 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.079709% | 2026-02-28 | 2026-02-28 |
| IBB | iShares Biotechnology ETF | 0.074418% | 2026-03-31 | 2026-03-31 |
| GWX | State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 0.07067% | 2026-03-31 | 2026-03-31 |
| BIB | ProShares Ultra Nasdaq Biotechnology | 0.054408% | 2026-02-28 | 2026-02-28 |
| PDN | Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | 0.047272% | 2026-04-30 | 2026-04-30 |
| SPDW | State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 0.00553% | 2026-03-31 | 2026-03-31 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.005411% | 2026-02-28 | 2026-02-28 |